ExodusPoint Capital Management’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$647K Sell
84,309
-283,572
-77% -$1.94M 0.01% 1120
2025
Q4
$728K Buy
367,881
+205,498
+127% +$466K 0.01% 1090
2025
Q3
$399K Buy
+162,383
New +$418K 0.01% 1237
2024
Q4
Sell
-135,029
Closed -$502K 1762
2024
Q3
$502K Buy
+135,029
New +$625K 0.01% 1183
2024
Q1
Sell
-23,558
Closed -$118K 1702
2023
Q4
$118K Buy
+23,558
New +$73.9K ﹤0.01% 1341
2023
Q2
Sell
-10,262
Closed -$19K 2036
2023
Q1
$19K Buy
+10,262
New +$31.9K ﹤0.01% 1691
2021
Q2
Sell
-35,312
Closed -$838K 2559
2021
Q1
$838K Buy
+35,312
New +$915K 0.02% 1019
2020
Q4
Sell
-11,892
Closed -$82K 2144
2020
Q3
$82K Sell
11,892
-85,579
-88% -$853K ﹤0.01% 1612
2020
Q2
$1.2M Buy
97,471
+15,850
+19% +$89.5K 0.04% 652
2020
Q1
$235K Sell
81,621
-10,532
-11% -$52.7K 0.02% 722
2019
Q4
$349K Buy
+92,153
New +$157K 0.01% 1058

Other funds holding IBRX